
Byterunners, the developer behind Drug Dealer Simulator 2, has said it "would not pursue any legal action against Schedule 1 in any shape or form" if it was the one in charge of calling the shots.
In case you're not caught up, Schedule 1 has been popping off since it launched in late March. It's a game that's all about drugs: Making 'em, branding 'em, selling 'em, all that good stuff. Just a couple weeks after its release, it emerged that the Movie Games S.A., the publisher for Drug Dealer Simulator 2—another game that is also all about drugs, if the name wasn't already a dead giveaway—was launching an investigation against Schedule 1 into potential copyright infringement.